Multicentre Selective Lymphadenectomy Trial 1: key primary data remain unavailable
Br J Dermatol
.
2022 Dec;187(6):997-998.
doi: 10.1111/bjd.21712.
Epub 2022 Jul 12.
Authors
Anthony Dixon
1
,
Athanassios Kyrgidis
2
,
Christopher Zachary
3
,
John Dixon
4
,
Catalin Popescu
5
,
Michael Sladden
6
,
Zoe Apalla
2
,
Stuart Anderson
7
,
Giuseppe Argenziano
8
,
Demitrios Ioannides
2
,
Alexander Nirenberg
1
,
Aimillios Lallas
2
,
Samuel Zagarella
9
,
Caterina Longo
10
,
Harvey Smith
11
,
Howard Steinman
12
,
Thrasivoulos Tzellos
13
,
Lloyd Cleaver
14
,
Ken Leahey
15
,
Christos C Zouboulis
16
,
J Meirion Thomas
17
Affiliations
1
Australasian College of Cutaneous Oncology, Melbourne, VIC, Australia.
2
Aristotle University of Thessaloniki, Thessaloniki, Greece.
3
University of California, Irvine, CA, USA.
4
Swinburne University of Technology, Melbourne, VIC, Australia.
5
Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
6
University of Tasmania, Launceston, TAS, Australia.
7
Maffra Medical Group, Maffra, VIC, Australia.
8
University of Campania, Campania, Italy.
9
University of Sydney, Sydney, NSW, Australia.
10
University of Modena and Reggio Emilia, Modena, Italy.
11
Oxford Dermatology, Perth, WA, Australia.
12
Campbell University, Buies Creek, NC, USA.
13
Arctic University of Norway, Tromsø, Norway.
14
A T Still University, Kirksville, MO, USA.
15
Harbour Medical Services, Adelaide, SA, Australia.
16
Brandenburg Medical School, Theodor Fontane and Faculty of Health Sciences, Brandenburg, Dessau, Germany.
17
Royal Marsden Hospital, Chelsea, London, UK.
PMID:
35730244
DOI:
10.1111/bjd.21712
No abstract available
Publication types
Multicenter Study
MeSH terms
Humans
Lymph Node Excision*
Lymphatic Metastasis
Neoplasm Staging